SBL
BIVV

Sargent Bickham Lagudis’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Sargent Bickham Lagudis’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-47
Closed -$3K – 832
2017
Q4 		$3K Buy
47
+37
+370% +$2.02K ﹤0.01% 744
2017
Q3 		$1K Hold
10
– – ﹤0.01% 806
2017
Q2 		$1K Buy
10
+5
+100% +$285 ﹤0.01% 763
2017
Q1 		$0 Buy
+5
New +$246 ﹤0.01% 796

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Sargent Bickham Lagudis's BIVV Position: Q1 2018 in Review

Sargent Bickham Lagudis sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 47 shares — an estimated $3K sold.

Sargent Bickham Lagudis first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $3K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Sargent Bickham Lagudis reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 47 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $3K.
  • Sargent Bickham Lagudis first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Sargent Bickham Lagudis's Bioverativ Inc. Common Stock position peaked at $3K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Sargent Bickham Lagudis's 13F filing for Q1 2018, filed 13 Sep 2021.